openPR Logo

Press Releases from Hypereosinophilic Syndrome Therapeutics-Pharma Proff (1 total)

Hypereosinophilic Syndrome Therapeutics- Pipeline Analysis 2018, Clinical Trials …

Hypereosinophilic syndrome is a group of rare blood disorders which is characterized by increased number of eosinophils. These eosinophils make their way into various tissues, causing inflammation and eventually organ dysfunction. Download the sample report at: https://www.pharmaproff.com/request-sample/1041 The most commonly involved organs in hypereosinophilic syndrome include heart, lung, skin and nervous system. The symptoms observed during hypereosinophilic syndrome are skin rashes, dizziness, memory loss or confusion, cough, fatigue, fever and mouth sores.

Go To Page:   1 2 3 4 5 6 7 8 9 10